DK0898708T3 - Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays - Google Patents
Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assaysInfo
- Publication number
- DK0898708T3 DK0898708T3 DK97920694T DK97920694T DK0898708T3 DK 0898708 T3 DK0898708 T3 DK 0898708T3 DK 97920694 T DK97920694 T DK 97920694T DK 97920694 T DK97920694 T DK 97920694T DK 0898708 T3 DK0898708 T3 DK 0898708T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- cyclin
- interaction
- estrogen receptor
- assays
- Prior art date
Links
- 108010058546 Cyclin D1 Proteins 0.000 title abstract 2
- 102100038595 Estrogen receptor Human genes 0.000 title abstract 2
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 title abstract 2
- 108010038795 estrogen receptors Proteins 0.000 title abstract 2
- 230000003993 interaction Effects 0.000 title abstract 2
- 238000003556 assay Methods 0.000 title 1
- 229940011871 estrogen Drugs 0.000 abstract 2
- 239000000262 estrogen Substances 0.000 abstract 2
- 238000005462 in vivo assay Methods 0.000 abstract 2
- 230000004913 activation Effects 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000000099 in vitro assay Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9608143.5A GB9608143D0 (en) | 1996-04-19 | 1996-04-19 | Assay |
| PCT/EP1997/001888 WO1997040378A1 (en) | 1996-04-19 | 1997-04-16 | Interaction of cyclin d1 and estrogen receptor and its use in assays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0898708T3 true DK0898708T3 (da) | 2002-03-04 |
Family
ID=10792355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97920694T DK0898708T3 (da) | 1996-04-19 | 1997-04-16 | Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6033843A (da) |
| EP (1) | EP0898708B1 (da) |
| JP (1) | JP2000508777A (da) |
| AT (1) | ATE308497T1 (da) |
| AU (1) | AU2698197A (da) |
| CA (1) | CA2249396A1 (da) |
| DE (1) | DE69708081T2 (da) |
| DK (1) | DK0898708T3 (da) |
| GB (1) | GB9608143D0 (da) |
| WO (1) | WO1997040378A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001519525A (ja) * | 1997-10-07 | 2001-10-23 | メルク エンド カムパニー インコーポレーテッド | Ｆｒｅｔを用いる核内受容体リガンドに関するアッセイ |
| ATE282826T1 (de) | 1998-02-12 | 2004-12-15 | Topotarget Uk Ltd | Interaktion zwischen cyclin d1 und koaktivatoren von steroidrezeptoren |
| US6210924B1 (en) * | 1998-08-11 | 2001-04-03 | Amgen Inc. | Overexpressing cyclin D 1 in a eukaryotic cell line |
| US20030175817A1 (en) * | 2000-02-10 | 2003-09-18 | Kyoji Ikeda | Method of screening for antiandrogen agent |
| ATE445164T1 (de) * | 2000-06-22 | 2009-10-15 | Univ Paris Descartes | Zusammensetzungen und methoden zum nachweis, behandeln oder vorhersagen der antwort von brust tumorzellen auf eine endocrin-therapie |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0905236A1 (en) * | 1992-10-29 | 1999-03-31 | Medical Research Council | Transcription factor DP-1 |
-
1996
- 1996-04-19 GB GBGB9608143.5A patent/GB9608143D0/en active Pending
-
1997
- 1997-04-16 DE DE69708081T patent/DE69708081T2/de not_active Expired - Fee Related
- 1997-04-16 DK DK97920694T patent/DK0898708T3/da active
- 1997-04-16 AT AT97920694T patent/ATE308497T1/de not_active IP Right Cessation
- 1997-04-16 EP EP97920694A patent/EP0898708B1/en not_active Expired - Lifetime
- 1997-04-16 US US09/171,151 patent/US6033843A/en not_active Expired - Fee Related
- 1997-04-16 WO PCT/EP1997/001888 patent/WO1997040378A1/en not_active Ceased
- 1997-04-16 AU AU26981/97A patent/AU2698197A/en not_active Abandoned
- 1997-04-16 CA CA002249396A patent/CA2249396A1/en not_active Abandoned
- 1997-04-16 JP JP9537692A patent/JP2000508777A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE308497T1 (de) | 2001-11-15 |
| DE69708081D1 (de) | 2001-12-13 |
| JP2000508777A (ja) | 2000-07-11 |
| DE69708081T2 (de) | 2002-07-04 |
| EP0898708B1 (en) | 2001-11-07 |
| GB9608143D0 (en) | 1996-06-26 |
| WO1997040378A1 (en) | 1997-10-30 |
| AU2698197A (en) | 1997-11-12 |
| EP0898708A1 (en) | 1999-03-03 |
| US6033843A (en) | 2000-03-07 |
| CA2249396A1 (en) | 1997-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200003513T2 (tr) | Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları | |
| PT1053256E (pt) | Anticorpos para o receptor de morte 4 (dr4) e utilizações destes | |
| CY1109267T1 (el) | Μεθοδοι για την καλλιεργεια κυκλοϊου | |
| DE69918072D1 (de) | P53-regulierte gene | |
| ATE309378T1 (de) | Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung | |
| BR9811956B1 (pt) | naftiridinonas e composição farmacêutica compreendendo as mesmas. | |
| IL117425A0 (en) | Receptor activation by gas6 | |
| ATE435655T1 (de) | Verwendung von agonistischen 4-1bb antikörpern zur erhöhung der immunantwort | |
| EP1616942A3 (en) | Patched genes and their use | |
| DK0922102T3 (da) | Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf | |
| DE69512219D1 (de) | Gezielte spaltung von rns mittels gezielter bindung der ribonuklease p und spaltungssequenzen | |
| TR200003377T2 (tr) | Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol | |
| DK0687294T3 (da) | Epitelcellelinier afledt af human lever | |
| ATE431416T1 (de) | Enzymatische synthese von deoxyribonucleotiden | |
| DK0701604T3 (da) | Immortalisering af dendritiske celler med V-myc-onkogenet | |
| ES8402346A1 (es) | Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente. | |
| DK0898708T3 (da) | Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays | |
| EP1450602A4 (en) | IDENTIFICATION AND CHARACTERIZATION OF GENES | |
| DE69426534D1 (de) | Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten | |
| FR2776188B1 (fr) | Oleamide de glycylglycine en dermo-cosmetologie | |
| DE59508100D1 (de) | Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander | |
| DK1144666T3 (da) | Replikationsdeficient baculovirusekspressionssystem | |
| HUP0101393A1 (hu) | Redukáló körülményekre érzékeny transzfektáló kompozíciók, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| EE200300156A (et) | Kasvajarakkude kasvufaktoritest sõltuvuse pärssimine | |
| EP1023459A4 (en) | DETERMINATION OF EXISTING QUANTITIES OF CYCLINE-DEPENDENT KINASE INHIBITOR P27 AS A PROGNOSTIC FACTOR IN CANCER PATIENTS |